ATE151283T1 - Arzneimittel mit kontrollierter wirkstoffabgabe - Google Patents

Arzneimittel mit kontrollierter wirkstoffabgabe

Info

Publication number
ATE151283T1
ATE151283T1 AT92902527T AT92902527T ATE151283T1 AT E151283 T1 ATE151283 T1 AT E151283T1 AT 92902527 T AT92902527 T AT 92902527T AT 92902527 T AT92902527 T AT 92902527T AT E151283 T1 ATE151283 T1 AT E151283T1
Authority
AT
Austria
Prior art keywords
active ingredients
controlled delivery
medicinal products
core
vinylpyrrolidine
Prior art date
Application number
AT92902527T
Other languages
English (en)
Inventor
John Michael Newton
Original Assignee
British Tech Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Tech Group filed Critical British Tech Group
Application granted granted Critical
Publication of ATE151283T1 publication Critical patent/ATE151283T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Lubricants (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Glass Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT92902527T 1990-11-22 1991-11-21 Arzneimittel mit kontrollierter wirkstoffabgabe ATE151283T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909025372A GB9025372D0 (en) 1990-11-22 1990-11-22 Pharmaceutical dosage forms
PCT/GB1991/002057 WO1992009270A1 (en) 1990-11-22 1991-11-21 Controlled release compositions

Publications (1)

Publication Number Publication Date
ATE151283T1 true ATE151283T1 (de) 1997-04-15

Family

ID=10685781

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92902527T ATE151283T1 (de) 1990-11-22 1991-11-21 Arzneimittel mit kontrollierter wirkstoffabgabe

Country Status (14)

Country Link
EP (1) EP0559813B1 (de)
JP (1) JPH06502636A (de)
KR (1) KR930701984A (de)
AT (1) ATE151283T1 (de)
AU (1) AU653372B2 (de)
CA (1) CA2096733A1 (de)
DE (1) DE69125619T2 (de)
ES (1) ES2101082T3 (de)
FI (1) FI932320A7 (de)
GB (2) GB9025372D0 (de)
HU (1) HUT65756A (de)
NO (1) NO931859L (de)
WO (1) WO1992009270A1 (de)
ZA (1) ZA919185B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY110880A (en) * 1991-01-30 1999-06-30 The Wellcome Foundation Ltd Water-dispersible tablets
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
TW246635B (de) * 1992-10-08 1995-05-01 Shell Internat Res Schappej B V
DK66493D0 (da) * 1993-06-08 1993-06-08 Ferring A S Praeparater, isaer til brug ved behandling af inflammatoriske tarmsygdomme eller til at opnaa forbedret saarheling
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
US6028190A (en) 1994-02-01 2000-02-22 The Regents Of The University Of California Probes labeled with energy transfer coupled dyes
US6166024A (en) 1995-03-30 2000-12-26 Mayo Foundation For Medical Education And Research Use of topical azathioprine and thioguanine to treat colorectal adenomas
HRP970485A2 (en) 1996-09-13 1998-08-31 Joerg Rosenberg Process for producing solid pharmaceutical forms
DE19649100A1 (de) * 1996-11-27 1998-06-04 Lohmann Therapie Syst Lts Verfahren zur verlustarmen Herstellung wirkstoffhaltiger scheibenförmiger Formkörper und diese enthaltende transdermale therapeutische Systeme
JP4533531B2 (ja) 1998-04-03 2010-09-01 ビーエム リサーチ エイ／エス 制御放出組成物
DE19840256A1 (de) * 1998-09-03 2000-03-09 Basf Ag Verfahren zur Herstellung von beschichteten festen Dosierungsformen
DE59905248D1 (de) 1999-01-29 2003-05-28 Disphar Int Bv Pharmazeutische zusammensetzungen
AU2001289653A1 (en) * 2000-07-14 2002-01-30 Universiteit Gent Composite solid shaped articles for the controlled delivery of biologically active ingredients
EP1429744A1 (de) 2001-09-21 2004-06-23 Egalet A/S Polymeres freigabungssystem mit morphin
US20040234602A1 (en) 2001-09-21 2004-11-25 Gina Fischer Polymer release system
US20030203027A1 (en) * 2002-04-26 2003-10-30 Ethicon, Inc. Coating technique for deposition of drug substance on a substrate
BR0309844A (pt) * 2002-05-07 2005-02-15 Control Delivery Sys Inc Processos para formação de um dispositivo para a distribuição de droga
GB0214013D0 (en) 2002-06-18 2002-07-31 Euro Celtique Sa Pharmaceutical product
EP1562552A1 (de) 2002-11-08 2005-08-17 Egalet A/S Zusammensetzung zur kontrollierten wirkstoffabgabe von carvedilol
ATE454886T1 (de) 2003-03-26 2010-01-15 Egalet As Matrixzubereitungen für die kontrollierte darreichung von arzneistoffen
WO2004084868A1 (en) 2003-03-26 2004-10-07 Egalet A/S Morphine controlled release system
DE102004042139B4 (de) * 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit
EP2155167A2 (de) 2007-06-04 2010-02-24 Egalet A/S Pharmazeutische zusammensetzungen mit gesteuerter freisetzung für verlängerte wirkung
NZ594207A (en) 2009-02-06 2013-03-28 Egalet Ltd Immediate release composition resistant to abuse by intake of alcohol
NZ597283A (en) 2009-06-24 2013-07-26 Egalet Ltd Controlled release formulations
WO2011107944A2 (en) * 2010-03-04 2011-09-09 Wockhardt Limited Modified release dosage form
BR112015000150A2 (pt) 2012-07-06 2017-06-27 Egalet Ltd composições farmacêuticas dissuasoras de abuso de liberação controlada
JP7407595B2 (ja) * 2016-10-05 2024-01-04 タイタン ファーマシューティカルズ インコーポレイテッド バースト放出を低減する薬剤送達用の埋込可能な装置

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
GB2170104A (en) * 1985-01-30 1986-07-30 Warner Lambert Co Coated pharmaceutical dosage forms
IE861284L (en) * 1986-05-14 1987-11-14 Birex Res And Dev Ltd And Carm Controlled release ketoprofen.
US4810501A (en) * 1986-06-17 1989-03-07 Warner-Lambert Company Sustained release pharmaceutical preparations
GB8618811D0 (en) * 1986-08-01 1986-09-10 Approved Prescription Services Sustained release ibuprofen formulation
US5158881A (en) * 1987-11-17 1992-10-27 Brown University Research Foundation Method and system for encapsulating cells in a tubular extrudate in separate cell compartments

Also Published As

Publication number Publication date
DE69125619T2 (de) 1997-09-11
NO931859D0 (no) 1993-05-21
KR930701984A (ko) 1993-09-08
WO1992009270A1 (en) 1992-06-11
ZA919185B (en) 1992-09-30
EP0559813B1 (de) 1997-04-09
FI932320L (fi) 1993-07-09
CA2096733A1 (en) 1992-05-23
HU9301499D0 (en) 1993-09-28
HUT65756A (en) 1994-07-28
DE69125619D1 (de) 1997-05-15
AU8909691A (en) 1992-06-25
GB9124776D0 (en) 1992-01-15
JPH06502636A (ja) 1994-03-24
ES2101082T3 (es) 1997-07-01
FI932320A7 (fi) 1993-07-09
GB2249957A (en) 1992-05-27
GB9025372D0 (en) 1991-01-09
AU653372B2 (en) 1994-09-29
NO931859L (no) 1993-07-21
FI932320A0 (fi) 1993-05-21
GB2249957B (en) 1994-11-23
EP0559813A1 (de) 1993-09-15

Similar Documents

Publication Publication Date Title
ATE151283T1 (de) Arzneimittel mit kontrollierter wirkstoffabgabe
CA2376226A1 (en) New formulation
FI853934L (fi) Doseringssystem som bestaor av flera enheter och har en belaeggning som tillaoter diffusion.
DE69109557D1 (de) Überzogene feste Arzneiform mit Verabreichungsmöglichkeit im Dickdarm.
ATE287260T1 (de) Formulierung mit einer vorgeformten öffnung zur gesteuerten freisetzung
DE69023896D1 (de) Zementhilfsmittel, dessen herstellung sowie zementzusammensetzung.
ATE201989T1 (de) Arzneimittel mit kontrollierter wirkstoffabgabe
ATE151285T1 (de) Orale arzneimittel mit kolonspezifischer freisetzung
DE69004214D1 (de) Arzneimittel mit verzögerter freisetzung und ph-gesteuerten membranüberzügen.
DE69636223D1 (de) Formulierung mit gesteuerter freisetzung für wasserlöslische arzneistoffe, in der eine auslauföffnung in situ gebildet wird
ATE269709T1 (de) Tablette mit verzögerter freigabe enthaltend einen blutzuckersenkenden wirkstoff und einen antihyperglyzemischen wirkstoff
AP2001002237A0 (en) Hydrogel-driven drug dosage form.
DE69909316D1 (de) Pharmazeutische formulierung mit omeprazol
CO4290346A1 (es) Formas de dosificacion de liberacion controlada de azitromicina
EE03594B1 (et) Depooravimiks sobiv farmatseutiline kompositsioon, selle valmistamismeetod ja kasutamine
AP9100285A0 (en) Substituted benzimidazoles,process for their preparation and their pharmaceutical use
AR009696A2 (es) Dispositivo inhalador para administrar un polvo seco medicamentoso, procedimiento para su realizacion y envase de burbujas para ser usado con dicho dispositivo.
FI964253A0 (fi) Kollageenivalmiste vaikuttavien aineiden säädellyksi vapauttamiseksi
EP0230264A3 (en) Pharmaceutical composition for nasal application, process for its preparation and its use
DE3877365D1 (de) Arzneimittel mit methylcellulose.
DE69120536D1 (de) Arzneimittel
ATE206911T1 (de) Feste arzneimittelform mit polymerem material verteiltem wirkstoff
IS4733A (is) Ný LH-RH mótlyf, framleiðsla þeirra og notkun, ásamt læknislyfjum sem innihalda samsetningarnar og framleiðsla þeirra
DE3772954D1 (de) Arzneimittel mit verzoegerter wirkstoffabgabe.
RU93041454A (ru) Композиция с управляемым выделением, способ ее получения

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties